Written by Vivien Sauchik

Pharmacies today dispense controlled substances under more scrutiny than at any point in recent memory. Prescription Drug Monitoring Programs (PDMPs), electronic prescribing mandates, insurer oversight, and stepped-up enforcement at both the state and federal level have all strengthened efforts to prevent diversion and inappropriate prescribing. Those safeguards do real work. They have also changed what it feels like to be a patient — particularly one managing chronic pain, ADHD, or an anxiety disorder who picks up the same medication month after month.

Meeting the legal requirements is part of every pharmacist's day. How those requirements get explained at the counter matters almost as much. A thirty-second conversation can decide whether a patient walks out feeling informed, frustrated, or quietly humiliated — and pharmacists who handle that conversation well are protecting both their patients and their licenses.

The Legal Framework

Pharmacists dispensing controlled substances answer to several overlapping bodies of law. In New York, the Internet System for Tracking Over-Prescribing (I-STOP) requires prescribers to consult the state's Prescription Monitoring Program Registry before issuing most Schedule II, III, and IV controlled substance prescriptions. N.Y. Public Health Law § 3343-a created the Registry and imposes that consultation requirement; pharmacists rely on the same data to identify potential concerns before a prescription is filled.

Federal law adds its own layer. Under the Controlled Substances Act, the Drug Enforcement Administration recognizes a "corresponding responsibility" — the prescriber writes the prescription, but the pharmacist shares the duty to ensure it was issued for a legitimate medical purpose. In practice, that means exercising professional judgment, and investigating red flags before dispensing rather than after. The DEA and the federal courts have reinforced this point consistently.

None of this is controversial as policy. But on the ground, these safeguards often look like extra questions, phone calls to the prescriber, or a prescription held overnight. The patient standing at the counter rarely sees the statute behind the delay.

The Human Side of Compliance

Consider a patient who has taken the same ADHD medication for ten years. She has answered the same questions — about her prescription, her insurance, her treatment history — more times than she can count. At some point, the questions stop feeling routine. Some patients get frustrated. Some get embarrassed. And some conclude, not unreasonably, that they are being treated as suspects because of the medication they happen to need.

Behavioral research offers a useful frame here: procedural justice. People are far more willing to accept an unwelcome decision when they believe the process behind it was fair and they were treated with respect. The delay itself matters less than how it was handled. A pharmacist who says "we run this check on every controlled prescription — it's a state requirement, not anything about you" has changed the entire character of the interaction, even though nothing about the outcome changed.

Respectful communication does not compete with regulatory compliance. It supports it, because patients who understand that a procedure is required by law — and applied to everyone — are much less likely to hear it as a personal accusation.

Reducing Legal Risk Through Communication

Consistent communication protects the pharmacy, too. When a long-time patient bristles at a new verification step, an explanation grounded in the legal requirement preserves the relationship while the pharmacy meets its obligations. Standardizing that explanation across staff reduces the odds of a misunderstanding — and if a complaint or a licensing board investigation ever surfaces, a pharmacy that can show it handled these conversations the same way every time is in a far stronger position.

Documentation matters just as much. Clear notes about calls to prescribers and the reasoning behind dispensing decisions create a contemporaneous record of the pharmacist's professional judgment, which is exactly what a board or a court will want to see.

Practical Considerations for Pharmacies

Pharmacies can strengthen both compliance and patient relationships by:

• Training staff to explain legal requirements clearly and respectfully.

• Applying verification procedures consistently across all patients.

• Documenting communications involving controlled substance concerns.

• Reviewing policies on I-STOP, DEA requirements, and state pharmacy regulations on a regular schedule.

• Examining workflows so that compliance steps don't delay patient care any more than they must.

Electronic prescribing systems, PDMP databases, and predictive analytics are now part of everyday pharmacy practice, and they have made it far easier to spot unusual prescribing patterns and meet regulatory obligations. But these tools work best when they inform a pharmacist's judgment rather than substitute for it. An algorithm can flag a prescription; it cannot have the conversation that follows.

Regulatory oversight will keep evolving, and pharmacies will keep adapting. Meeting the legal obligations is non-negotiable. So, though, is the way pharmacists talk to the people they serve. Patients who understand why the questions are being asked tend to trust the process — and good pharmacy practice has always required more than data and regulation. It requires upholding the law while treating every patient with dignity.

References

• Controlled Substances Act, 21 U.S.C. § 801 et seq.

• Drug Enforcement Administration, Pharmacist's Manual: An Informational Outline of the Controlled Substances Act.

• N.Y. Public Health Law § 3343-a.

• New York State Department of Health, Internet System for Tracking Over-Prescribing (I-STOP).

• New York State Education Department, Board of Pharmacy Guidance.